鈣網蛋白(CALR)活性蛋白
Active Calreticulin (CALR)
CRT; RO; SSA; CC1qR; ERp60; HACBP; grp60; CRTC; CRP55; Calregulin; Sicca Syndrome Antigen A; Autoantigen Ro; Endoplasmic reticulum resident protein 60
- 編號APB486Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點4.3
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1814 ¥ 4536 ¥ 9072 ¥ 27216 ¥ 68040
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
活性實驗

Calreticulin (CALR) is an endoplasmic reticulum (ER)-resident protein involved in a spectrum of cellular processes. In healthy cells, CALR operates as a chaperone and Ca2 ?buffer to assist correct protein folding within the ER. Calreticulin is also found in the nucleus, suggesting that it may have a role in transcription regulation. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin. Recurrent mutations in calreticulin have been linked to various neoplasms, including the myeloproliferative type. Adhesive glycoprotein THBS1 has been shown to play roles in platelet aggregation, angiogenesis and tumorigenesis, the protein is an interactor of CALR, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CALR and recombinant rat THBS1. Briefly, biotin-linked CALR were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to THBS1-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μl stop solution to the wells and read at 450 nm immediately. The binding activity of CALR andTHBS1 was shown in Figure 1, the EC50?for this effect is 0.018 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
APB486Hu61 | 鈣網蛋白(CALR)活性蛋白 | Cell?culture;?Activity?Assays. |
EPB486Hu61 | 鈣網蛋白(CALR)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu03 | 鈣網蛋白(CALR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu02 | 鈣網蛋白(CALR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB486Hu01 | 鈣網蛋白(CALR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPB486Hu21 | 鈣網蛋白(CALR)卵白蛋白偶聯物 | Immunogen; SDS-PAGE; WB. |
PAB486Hu02 | 鈣網蛋白(CALR)多克隆抗體 | WB; IHC; ICC; IP; FCM |
PAB486Hu01 | 鈣網蛋白(CALR)多克隆抗體 | WB; IHC; ICC; IP; FCM |
PAB486Hu08 | 鈣網蛋白(CALR)多克隆抗體 | WB; IHC; ICC; IP. |
LAB486Hu71 | 鈣網蛋白(CALR)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAB486Hu22 | 鈣網蛋白(CALR)單克隆抗體 | WB; IHC; ICC; IP. |
SEB486Hu | 鈣網蛋白(CALR)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEB486Hu | 鈣網蛋白(CALR)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB486Hu | 鈣網蛋白(CALR)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB486Hu01 | 鈣網蛋白(CALR)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Journal of Investigative Dermatology | Oxidative Stress-Induced Calreticulin Expression and Translocation: New Insights into the Destruction of Melanocytes [Pubmed: 23771121] |
International Journal of Molecular Sciences | The Anticoagulant Effect of PGI2S and tPA in Transgenic Umbilical Vein Endothelial Cells Is Linked to Up-Regulation of PKA and PKC [Mdpi: Source] |
The Journal of Maternal-Fetal & Neonatal Medicine | Amniotic fluid calreticulin in pregnancies complicated by the preterm prelabor rupture of membranes [Pubmed:26953684] |
journal of maternal-fetal & neonatal medicine | Cervical fluid calreticulin and cathepsin-G in pregnancies complicated by preterm prelabor rupture of membranes. [pubmed:28152632] |
Talanta | Investigation of the interaction between calreticulin and immunoglobulin G by capillary electrophoresis and computer modeling [Doi: 10.1016/j.talanta.2018.11.098] |
Sci Adv | Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia [Pubmed:35171673] |